A detailed history of Essential Planning, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Essential Planning, Llc. holds 12,297 shares of LLY stock, worth $11.1 Million. This represents 4.58% of its overall portfolio holdings.

Number of Shares
12,297
Previous 12,297 -0.0%
Holding current value
$11.1 Million
Previous $7.17 Million 33.45%
% of portfolio
4.58%
Previous 3.62%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.01%
12,297 $7.17 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $14,731 - $19,697
-42 Reduced 0.34%
12,296 $5.77 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $621 - $729
2 Added 0.02%
12,338 $4.24 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $3.97 Million - $4.62 Million
12,336 New
12,336 $4.51 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Essential Planning, Llc. Portfolio

Follow Essential Planning, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essential Planning, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Essential Planning, Llc. with notifications on news.